bleomycetin has been researched along with Facial Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, X; Hou, R; Lei, D; Liu, Y; Sun, M; Wang, L; Yan, Z; Yang, Y | 1 |
Luo, Q; Zhao, F | 1 |
Luo, QF; Zhao, FY | 1 |
Hou, J; Huang, H; Tang, H; Wang, M; Wang, Y | 1 |
4 other study(ies) available for bleomycetin and Facial Neoplasms
Article | Year |
---|---|
Preliminary study of fibrin glue combined with pingyangmycin for the treatment of venous malformations in the oral and maxillofacial region.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Arteriovenous Malformations; Bleomycin; Child; Drug Combinations; Facial Neoplasms; Female; Fibrin Tissue Adhesive; Hemangioma, Cavernous; Humans; Injections, Intralesional; Magnetic Resonance Angiography; Male; Mouth Neoplasms; Sclerosing Solutions; Treatment Outcome; Ultrasonography, Doppler | 2008 |
How to use bleomycin A5 for infantile maxillofacial haemangiomas: clinical evaluation of 82 consecutive cases.
Topics: Antibiotics, Antineoplastic; Bleomycin; Drug Therapy, Combination; Facial Neoplasms; Female; Glucocorticoids; Hemangioma, Capillary; Humans; Infant; Injections, Intralesional; Male; Neoplastic Syndromes, Hereditary; Prednisone; Sclerosing Solutions; Treatment Outcome | 2011 |
The effects of Bleomycin A5 on infantile maxillofacial haemangioma.
Topics: Antibiotics, Antineoplastic; Bleomycin; Dose-Response Relationship, Drug; Facial Neoplasms; Female; Hemangioma; Humans; Infant; Infant, Newborn; Injections, Intralesional; Magnetic Resonance Imaging; Male; Maxillary Neoplasms; Retrospective Studies; Treatment Outcome | 2011 |
Pingyangmycin sclerotherapy for infantile hemangiomas in oral and maxillofacial regions: an evaluation of 66 consecutive patients.
Topics: Antibiotics, Antineoplastic; Bleomycin; Dose-Response Relationship, Drug; Facial Neoplasms; Female; Follow-Up Studies; Hemangioma; Humans; Infant; Injections, Intralesional; Male; Maxillary Neoplasms; Mouth Neoplasms; Sclerosing Solutions; Sclerotherapy; Treatment Outcome | 2011 |